Oscar Health, Inc.
OSCR
$17.11
$0.050.29%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 42.37% | 67.44% | 68.61% | 46.01% | 45.88% |
| Total Other Revenue | -23.15% | -15.93% | -11.59% | 2.87% | 12.61% |
| Total Revenue | 42.20% | 67.11% | 68.30% | 45.86% | 45.77% |
| Cost of Revenue | 45.34% | 71.34% | 72.28% | 44.56% | 42.43% |
| Gross Profit | 33.88% | 44.56% | 51.56% | 50.39% | 55.39% |
| SG&A Expenses | 22.48% | 27.92% | 41.28% | 29.05% | -1.09% |
| Depreciation & Amortization | -13.84% | 19.26% | -18.40% | -13.83% | 58.15% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.50% | 61.06% | 64.98% | 40.80% | 30.88% |
| Operating Income | 60.12% | -1.55% | 16.95% | 1,138.63% | 831.55% |
| Income Before Tax | 61.48% | -2.02% | 19.26% | 527.38% | 574.59% |
| Income Tax Expenses | 1,175.60% | 49.88% | 126.89% | 298.37% | -50.72% |
| Earnings from Continuing Operations | 55.23% | -2.30% | 17.22% | 465.07% | 547.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -106.14% | -36.46% | -168.20% | -1.94% | 20.83% |
| Net Income | 55.20% | -2.34% | 16.52% | 461.97% | 545.96% |
| EBIT | 60.12% | -1.55% | 16.95% | 1,138.63% | 831.55% |
| EBITDA | 57.14% | -0.55% | 16.67% | 3,188.84% | 1,046.68% |
| EPS Basic | 42.94% | 6.37% | 23.37% | 432.63% | 517.88% |
| Normalized Basic EPS | 48.68% | 6.62% | 24.88% | 487.35% | 541.74% |
| EPS Diluted | 47.21% | -3.57% | 23.37% | 388.28% | 439.91% |
| Normalized Diluted EPS | 55.02% | 6.62% | 24.88% | 404.14% | 447.98% |
| Average Basic Shares Outstanding | 8.57% | 9.30% | 8.97% | 8.78% | 6.70% |
| Average Diluted Shares Outstanding | 4.13% | 9.30% | 8.97% | 38.54% | 35.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |